Advertisement
Screener

ENANTA PHARMACEUTICALS, INC (ENTA) Increase (Decrease) in Prepaid Expense and Other Assets

2.8 / 5 stars · 68/120 Roast Me

ENANTA PHARMACEUTICALS, INC Increase (Decrease) in Prepaid Expense and Other Assets

ENANTA PHARMACEUTICALS, INC (ENTA) reported Increase (Decrease) in Prepaid Expense and Other Assets of -$1.01 million for the 9-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.

Financial Statements › Cash Flow › Operating Activities

us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets · last filed 2026-08-12

  • ENANTA PHARMACEUTICALS, INC increase (decrease) in prepaid expense and other assets for the quarter ending 2026-06-30 was $769.00K, a 44.40% decline year-over-year.
  • ENANTA PHARMACEUTICALS, INC increase (decrease) in prepaid expense and other assets for the quarter ending 2026-03-31 was $2.47M.
  • ENANTA PHARMACEUTICALS, INC increase (decrease) in prepaid expense and other assets for the quarter ending 2025-12-31 was -$4.25M.
  • ENANTA PHARMACEUTICALS, INC increase (decrease) in prepaid expense and other assets for the quarter ending 2025-09-30 was -$1.65M.
  • ENANTA PHARMACEUTICALS, INC increase (decrease) in prepaid expense and other assets for fiscal 2025 was -$3.82M.
  • ENANTA PHARMACEUTICALS, INC increase (decrease) in prepaid expense and other assets for fiscal 2024 was -$850.00K.
  • ENANTA PHARMACEUTICALS, INC increase (decrease) in prepaid expense and other assets for fiscal 2023 was -$182.00K.
  • ENANTA PHARMACEUTICALS, INC increase (decrease) in prepaid expense and other assets for fiscal 2022 was -$743.00K, a 239.40% decline from fiscal 2021.
Period endIncrease (Decrease) in Prepaid Expense and Other Assets 3 monthIncrease (Decrease) in Prepaid Expense and Other Assets 3 month as first filedIncrease (Decrease) in Prepaid Expense and Other Assets 6 monthIncrease (Decrease) in Prepaid Expense and Other Assets 9 monthIncrease (Decrease) in Prepaid Expense and Other Assets 9 month as first filedIncrease (Decrease) in Prepaid Expense and Other Assets 12 monthIncrease (Decrease) in Prepaid Expense and Other Assets 12 month as first filed
2026-06-30$769.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2026-08-12
$3.24M
derived: sum of 2 quarters · filed 2026-08-12
-$1.01M
10-Q · filed 2026-08-12
-$2.66M
derived: sum of 4 quarters · filed 2026-08-12
2026-03-31$2.47M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-05-13
-$1.78M
10-Q · filed 2026-05-13
-$3.43M
derived: sum of 3 quarters · filed 2026-05-13
-$2.05M
derived: sum of 4 quarters · filed 2026-08-12
2025-12-31-$4.25M
10-Q · filed 2026-02-11
-$5.90M
derived: sum of 2 quarters · filed 2026-02-11
-$4.51M
derived: sum of 3 quarters · filed 2026-08-12
-$6.34M
derived: sum of 4 quarters · filed 2026-08-12
2025-09-30-$1.65M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-11-19
-$267.00K
derived: sum of 2 quarters · filed 2026-08-12
-$2.09M
derived: sum of 3 quarters · filed 2026-08-12
-$3.82M
10-K · filed 2025-11-19
2025-06-30$1.38M
derived: 10-Q 9 month − 10-Q 6 month · filed 2026-08-12
-$444.00K
derived: sum of 2 quarters · filed 2026-08-12
-$2.17M
10-Q · filed 2026-08-12
-$5.02M
derived: sum of 4 quarters · filed 2026-08-12
2025-03-31-$1.83M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-05-13
-$3.56M
10-Q · filed 2026-05-13
-$6.40M
derived: sum of 3 quarters · filed 2026-05-13
-$2.08M
derived: sum of 4 quarters · filed 2026-05-13
2024-12-31-$1.73M
10-Q · filed 2026-02-11
-$4.58M
derived: sum of 2 quarters · filed 2026-02-11
-$248.00K
derived: sum of 3 quarters · filed 2026-02-11
-$2.56M
derived: sum of 4 quarters · filed 2026-02-11
2024-09-30-$2.85M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-11-19
$1.48M
derived: sum of 2 quarters · filed 2025-11-19
-$832.00K
derived: sum of 3 quarters · filed 2025-11-19
-$850.00K
10-K · filed 2025-11-19
2024-06-30$4.33M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-08-13
$2.02M
derived: sum of 2 quarters · filed 2025-08-13
$2.00M
10-Q · filed 2025-08-13
-$1.81M
derived: sum of 4 quarters · filed 2025-11-19
2024-03-31-$2.31M
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-05-14
-$2.33M
10-Q · filed 2025-05-14
-$6.14M
derived: sum of 3 quarters · filed 2025-11-19
-$3.55M
derived: sum of 4 quarters · filed 2025-11-19
2023-12-31-$18.00K
10-Q · filed 2025-02-12
-$3.83M
derived: sum of 2 quarters · filed 2025-11-19
-$1.24M
derived: sum of 3 quarters · filed 2025-11-19
-$4.70M
derived: sum of 4 quarters · filed 2025-11-19
2023-09-30-$3.81M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-11-19
-$1.22M
derived: sum of 2 quarters · filed 2025-11-19
-$4.68M
derived: sum of 3 quarters · filed 2025-11-19
-$182.00K
10-K · filed 2025-11-19
2023-06-30$2.59M
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-08-07
-$875.00K
derived: sum of 2 quarters · filed 2024-08-07
$3.63M
10-Q · filed 2024-08-07
$5.53M
derived: sum of 4 quarters · filed 2024-11-27
2023-03-31-$3.46M
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-05-08
$1.04M
10-Q · filed 2024-05-08
$2.94M
derived: sum of 3 quarters · filed 2024-11-27
$406.00K
derived: sum of 4 quarters · filed 2024-11-27
2022-12-31$4.50M
10-Q · filed 2024-02-08
$6.41M
derived: sum of 2 quarters · filed 2024-11-27
$3.87M
derived: sum of 3 quarters · filed 2024-11-27
$6.44M
derived: sum of 4 quarters · filed 2024-11-27
2022-09-30$1.91M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-11-27
-$633.00K
derived: sum of 2 quarters · filed 2024-11-27
$1.94M
derived: sum of 3 quarters · filed 2024-11-27
-$743.00K
10-K · filed 2024-11-27
2022-06-30-$2.54M
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-08-08
$34.00K
derived: sum of 2 quarters · filed 2023-08-08
-$2.65M
10-Q · filed 2023-08-08
-$597.00K
derived: sum of 4 quarters · filed 2023-11-22
2022-03-31$2.57M
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-05-09
-$110.00K
10-Q · filed 2023-05-09
$1.94M
derived: sum of 3 quarters · filed 2023-11-22
-$5.02M
derived: sum of 4 quarters · filed 2023-11-22
2021-12-31-$2.68M
10-Q · filed 2023-02-08
-$631.00K
derived: sum of 2 quarters · filed 2023-11-22
-$7.59M
derived: sum of 3 quarters · filed 2023-11-22
-$6.64M
derived: sum of 4 quarters · filed 2023-11-22
2021-09-30$2.05M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-11-22
-$4.91M
derived: sum of 2 quarters · filed 2023-11-22
-$3.96M
derived: sum of 3 quarters · filed 2023-11-22
$533.00K
10-K · filed 2023-11-22
2021-06-30-$6.96M
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-08-08
-$6.01M
derived: sum of 2 quarters · filed 2022-08-08
-$1.52M
10-Q · filed 2022-08-08
$591.00K
derived: sum of 4 quarters · filed 2022-11-23
2021-03-31$948.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-05-09
$5.44M
10-Q · filed 2022-05-09
$7.55M
derived: sum of 3 quarters · filed 2022-11-23
$8.18M
derived: sum of 4 quarters · filed 2022-11-23
2020-12-31$4.50M
10-Q · filed 2022-02-10
$1.31M
10-Q · filed 2021-02-09
$6.61M
derived: sum of 2 quarters · filed 2022-11-23
$7.23M
derived: sum of 3 quarters · filed 2022-11-23
$12.91M
derived: sum of 4 quarters · filed 2022-11-23
2020-09-30$2.11M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-11-23
$2.73M
derived: sum of 2 quarters · filed 2022-11-23
$8.42M
derived: sum of 3 quarters · filed 2022-11-23
$7.27M
10-K · filed 2022-11-23
$11.40M
10-K · filed 2020-11-25
2020-06-30$625.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-08-09
$6.31M
derived: sum of 2 quarters · filed 2021-08-09
$5.16M
10-Q · filed 2021-08-09
$9.43M
10-Q · filed 2020-08-10
-$6.10M
derived: sum of 4 quarters · filed 2021-11-24
2020-03-31$5.68M
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-05-10
$4.54M
10-Q · filed 2021-05-10
-$6.73M
derived: sum of 3 quarters · filed 2021-11-24
-$3.13M
derived: sum of 4 quarters · filed 2021-11-24
2019-12-31-$1.15M
10-Q · filed 2021-02-09
-$12.41M
derived: sum of 2 quarters · filed 2021-11-24
-$8.81M
derived: sum of 3 quarters · filed 2021-11-24
-$2.40M
derived: sum of 4 quarters · filed 2021-11-24
2019-09-30-$11.26M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-11-24
-$7.67M
derived: sum of 2 quarters · filed 2021-11-24
-$1.25M
derived: sum of 3 quarters · filed 2021-11-24
$1.93M
10-K · filed 2021-11-24
$10.85M
10-K · filed 2019-11-27
2019-06-30$3.60M
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-08-10
$10.01M
derived: sum of 2 quarters · filed 2020-08-10
$13.19M
10-Q · filed 2020-08-10
$8.24M
derived: sum of 4 quarters · filed 2020-11-25
2019-03-31$6.42M
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-05-11
$9.60M
10-Q · filed 2020-05-11
$4.65M
derived: sum of 3 quarters · filed 2020-11-25
$9.15M
derived: sum of 4 quarters · filed 2020-11-25
2018-12-31$3.18M
10-Q · filed 2020-02-10
-$1.77M
derived: sum of 2 quarters · filed 2020-11-25
$2.73M
derived: sum of 3 quarters · filed 2020-11-25
$3.56M
derived: sum of 4 quarters · filed 2020-11-25
2018-09-30-$4.95M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-11-25
-$451.00K
derived: sum of 2 quarters · filed 2020-11-25
$379.00K
derived: sum of 3 quarters · filed 2020-11-25
$918.00K
10-K · filed 2020-11-25
2018-06-30$4.50M
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-08-09
$5.33M
derived: sum of 2 quarters · filed 2019-08-09
$5.87M
10-Q · filed 2019-08-09
$2.77M
derived: sum of 4 quarters · filed 2019-11-27
2018-03-31$830.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-05-10
$1.37M
10-Q · filed 2019-05-10
-$1.73M
derived: sum of 3 quarters · filed 2019-11-27
-$1.20M
derived: sum of 4 quarters · filed 2019-11-27
2017-12-31$539.00K
10-Q · filed 2019-02-08
-$2.56M
derived: sum of 2 quarters · filed 2019-11-27
-$2.02M
derived: sum of 3 quarters · filed 2019-11-27
-$198.00K
derived: sum of 4 quarters · filed 2019-11-27
2017-09-30-$3.09M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-11-27
-$2.56M
derived: sum of 2 quarters · filed 2019-11-27
-$737.00K
derived: sum of 3 quarters · filed 2019-11-27
-$5.68M
10-K · filed 2019-11-27
2017-06-30$530.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-08-09
$2.36M
derived: sum of 2 quarters · filed 2018-08-09
-$2.58M
10-Q · filed 2018-08-09
-$1.55M
derived: sum of 4 quarters · filed 2018-11-29
2017-03-31$1.83M
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-05-10
-$3.11M
10-Q · filed 2018-05-10
-$2.08M
derived: sum of 3 quarters · filed 2018-11-29
-$1.54M
derived: sum of 4 quarters · filed 2018-11-29
2016-12-31-$4.94M
10-Q · filed 2018-02-09
-$3.91M
derived: sum of 2 quarters · filed 2018-11-29
-$3.37M
derived: sum of 3 quarters · filed 2018-11-29
-$4.25M
derived: sum of 4 quarters · filed 2018-11-29
2016-09-30$1.03M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-11-29
$1.57M
derived: sum of 2 quarters · filed 2018-11-29
$688.00K
derived: sum of 3 quarters · filed 2018-11-29
$964.00K
10-K · filed 2018-11-29
2016-06-30$542.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-08-09
-$343.00K
derived: sum of 2 quarters · filed 2017-08-09
-$67.00K
10-Q · filed 2017-08-09
$5.50M
derived: sum of 4 quarters · filed 2017-12-11
2016-03-31-$885.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-05-10
-$609.00K
10-Q · filed 2017-05-10
$4.96M
derived: sum of 3 quarters · filed 2017-12-11
$6.11M
derived: sum of 4 quarters · filed 2017-12-11
2015-12-31$276.00K
10-Q · filed 2017-02-09
$5.85M
derived: sum of 2 quarters · filed 2017-12-11
$7.00M
derived: sum of 3 quarters · filed 2017-12-11
$7.37M
derived: sum of 4 quarters · filed 2017-12-11
2015-09-30$5.57M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-12-11
$6.72M
derived: sum of 2 quarters · filed 2017-12-11
$7.09M
derived: sum of 3 quarters · filed 2017-12-11
$6.68M
10-K · filed 2017-12-11
2015-06-30$1.15M
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-08-09
$1.52M
derived: sum of 2 quarters · filed 2016-08-09
$1.11M
10-Q · filed 2016-08-09
$701.00K
derived: sum of 4 quarters · filed 2016-12-09
2015-03-31$367.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-05-10
-$42.00K
10-Q · filed 2016-05-10
-$449.00K
derived: sum of 3 quarters · filed 2016-12-09
-$903.00K
derived: sum of 4 quarters · filed 2016-12-09
2014-12-31-$409.00K
10-Q · filed 2016-02-09
-$816.00K
derived: sum of 2 quarters · filed 2016-12-09
-$1.27M
derived: sum of 3 quarters · filed 2016-12-09
-$572.00K
derived: sum of 4 quarters · filed 2016-12-09
2014-09-30-$407.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2016-12-09
-$861.00K
derived: sum of 2 quarters · filed 2016-12-09
-$163.00K
derived: sum of 3 quarters · filed 2016-12-09
-$568.00K
10-K · filed 2016-12-09
2014-06-30-$454.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-08-10
$244.00K
derived: sum of 2 quarters · filed 2015-08-10
-$161.00K
10-Q · filed 2015-08-10
-$145.00K
derived: sum of 4 quarters · filed 2015-12-11
2014-03-31$698.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-05-08
$293.00K
10-Q · filed 2015-05-08
$309.00K
derived: sum of 3 quarters · filed 2015-12-11
$871.00K
derived: sum of 4 quarters · filed 2015-12-11
2013-12-31-$405.00K
10-Q · filed 2015-02-06
-$389.00K
derived: sum of 2 quarters · filed 2015-12-11
$173.00K
derived: sum of 3 quarters · filed 2015-12-11
-$84.00K
derived: sum of 4 quarters · filed 2015-12-11
2013-09-30$16.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2015-12-11
$578.00K
derived: sum of 2 quarters · filed 2015-12-11
$321.00K
derived: sum of 3 quarters · filed 2015-12-11
$307.00K
10-K · filed 2015-12-11
2013-06-30$562.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-08-12
$305.00K
derived: sum of 2 quarters · filed 2014-08-12
$291.00K
10-Q · filed 2014-08-12
$367.00K
derived: sum of 4 quarters · filed 2014-12-11
2013-03-31-$257.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-05-12
-$271.00K
10-Q · filed 2014-05-12
-$195.00K
derived: sum of 3 quarters · filed 2014-12-11
-$42.00K
derived: sum of 4 quarters · filed 2014-12-11
2012-12-31-$14.00K
10-Q · filed 2014-02-13
$62.00K
derived: sum of 2 quarters · filed 2014-12-11
$215.00K
derived: sum of 3 quarters · filed 2014-12-11
2012-09-30$76.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2014-12-11
$229.00K
derived: sum of 2 quarters · filed 2014-12-11
$235.00K
10-K · filed 2014-12-11
2012-06-30$153.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-08-12
$159.00K
10-Q · filed 2013-08-12
2012-03-31$6.00K
10-Q · filed 2013-05-15
2011-09-30$273.00K
10-K · filed 2013-12-18

Similar stocks

Stock NameCountryMarket CapPE Ratio
Emergent BioSolutions Inc. (EBS)United States$0.347B-2.43
Larimar Therapeutics, Inc. (LRMR)United States$0.344B-1.83
Vogenx, Inc. (VOGX)United States$0.355B
Benitec Biopharma Inc. (BNTC)United States$0.337B-10.08
BioAge Labs, Inc. (BIOA)United States$0.333B-11.88
BridgeBio Oncology Therapeutics, Inc. (BBOT)United States$0.320B-3.35
Evommune, Inc. (EVMN)United States$0.320B-5.10
Prelude Therapeutics Inc (PRLD)United States$0.318B-7.01
Rezolute, Inc. (RZLT)United States$0.382B-6.45
ABEONA THERAPEUTICS INC. (ABEO)United States$0.312B-5.63